Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook

血脂异常 医学 内科学 剩余风险 胆固醇 风险因素 代谢综合征 脂蛋白 内分泌学 糖尿病 甘油三酯 肥胖
作者
Vikrama Raja,Carlos Aguíar,Nasreen Al-Sayed,Yogeyaa S. Chibber,Hussein ElBadawi,М. В. Ежов,Michel P. Hermans,Ramesh C. Pandey,Kausik K. Ray,Lâle Tokgözoğlu,Alberto Zambon,Jean‐Pascal Berrou,Michel Farnier
出处
期刊:Atherosclerosis [Elsevier BV]
卷期号:383: 117312-117312 被引量:60
标识
DOI:10.1016/j.atherosclerosis.2023.117312
摘要

Dyslipidemia refers to unhealthy changes in blood lipid composition and is a risk factor for atherosclerotic cardiovascular diseases (ASCVD). Usually, low-density lipoprotein-cholesterol (LDL-C) is the primary goal for dyslipidemia management. However, non-high-density lipoprotein cholesterol (non-HDL-C) has gained attention as an alternative, reliable goal. It encompasses all plasma lipoproteins like LDL, triglyceride-rich lipoproteins (TRL), TRL-remnants, and lipoprotein a [Lp(a)] except high-density lipoproteins (HDL). In addition to LDL-C, several other constituents of non-HDL-C have been reported to be atherogenic, aiding the pathophysiology of atherosclerosis. They are acknowledged as contributors to residual ASCVD risk that exists in patients on statin therapy with controlled LDL-C levels. Therefore, non-HDL-C is now considered an independent risk factor or predictor for CVD. The popularity of non-HDL-C is attributed to its ease of estimation and non-dependency on fasting status. It is also better at predicting ASCVD risk in patients on statin therapy, and/or in those with obesity, diabetes, and metabolic disorders. In addition, large follow-up studies have reported that individuals with higher baseline non-HDL-C at a younger age (<45 years) were more prone to adverse CVD events at an older age, suggesting a predictive ability of non-HDL-C over the long term. Consequently, non-HDL-C is recommended as a secondary goal for dyslipidemia management by most international guidelines. Intriguingly, geographical patterns in recent epidemiological studies showed remarkably high non-HDL-C attributable mortality in high-risk countries. This review highlights the independent role of non-HDL-C in ASCVD pathogenesis and prognosis. In addition, the need for a country-specific approach to dyslipidemia management at the community/population level is discussed. Overall, non-HDL-C can become a co-primary or primary goal in dyslipidemia management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
思源应助傻傻的芹菜采纳,获得10
刚刚
ly发布了新的文献求助10
刚刚
成就老太完成签到 ,获得积分10
1秒前
蕾蕾完成签到 ,获得积分10
1秒前
cui123完成签到 ,获得积分10
1秒前
木棉发布了新的文献求助10
2秒前
坚果完成签到 ,获得积分10
2秒前
www完成签到,获得积分20
2秒前
2秒前
123完成签到,获得积分10
2秒前
2秒前
3秒前
2531完成签到,获得积分10
3秒前
腾腾完成签到 ,获得积分10
3秒前
3秒前
科研搬运工完成签到,获得积分10
4秒前
4秒前
4秒前
慕青应助焱阳采纳,获得10
4秒前
小蘑菇应助fusheng采纳,获得10
5秒前
11完成签到,获得积分10
5秒前
俊逸的绿竹关注了科研通微信公众号
5秒前
5秒前
6秒前
哈哈哈的一笑完成签到,获得积分10
6秒前
2531发布了新的文献求助10
6秒前
无心的怜烟完成签到,获得积分10
6秒前
6秒前
shitou完成签到,获得积分10
6秒前
liuz完成签到,获得积分0
6秒前
kimi发布了新的文献求助30
6秒前
顾夏包发布了新的文献求助10
7秒前
willam完成签到,获得积分10
7秒前
lhh发布了新的文献求助10
7秒前
mmddlj完成签到 ,获得积分10
8秒前
eleven发布了新的文献求助10
8秒前
8秒前
9秒前
科研通AI5应助free采纳,获得10
9秒前
mmmmmMM完成签到,获得积分10
9秒前
高分求助中
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
いちばんやさしい生化学 500
Comprehensive Supramolecular Chemistry II 500
The First Nuclear Era: The Life and Times of a Technological Fixer 500
Avialinguistics:The Study of Language for Aviation Purposes 270
Andrew Duncan Senior: Physician of the Enlightenment 240
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3682038
求助须知:如何正确求助?哪些是违规求助? 3233929
关于积分的说明 9811743
捐赠科研通 2945371
什么是DOI,文献DOI怎么找? 1615200
邀请新用户注册赠送积分活动 762655
科研通“疑难数据库(出版商)”最低求助积分说明 737533